Received May 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 1 | 024c21a | IM / LA |
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 034c21a | IM / LA |
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 3 | — | IM / LA |
Following dose 3 (12/13/2021), patient experienced extreme fatigue and mental confusion (brain fog) lasting more than 4 months. Patient was unable to seek medical care due to lack of health insurance at the time.
None
None
None
None
No medical tests performed at time of adverse event due to lack of health insurance.
Dose 2 (06/09/2021), age 30, COVID-19 mRNA Moderna. Left arm turned purple/blue and neck stiffness follow